… -spectrum antiviral agents and strategies against SARS-CoV-2 and future pathogenic viruses.
… the potential inhibitors, antiviral drugs and nanomaterials screened against SARS-CoV-2. …

… achieved in searching for drugs inhibiting the M pro , … potential inhibitors targeting SARS-CoV-2
M pro , identifies gaps, and provides future directions. Further, compounds with potential …

… inhibitors of COVID-19 protease, there is a demand to conduct a comprehensive review of the
most important studies to reveal and compare the potential … for adjusting antiviral inhibitors, …

… We also found that Glu166 forms H-bonds to all of the inhibitors. Replacing … to SARS-CoV-2
Mpro. Our results could contribute to the development of potential drugs inhibiting SARS-CoV…

… SARS-CoV-2 after intravenous treatment [12], while Chloroquine and Hydroxychloroquine
are being reported to be potential inhibitors of SARS-CoV-2 … its efficacy against SARS-CoV-2. …

… inhibitors, antiarrhythmic agents or CNS drugs emerged showing antiviral potency with 2 <
EC50 ≤ 20 µM. By providing new information on molecules inhibiting SARS-CoV-… SARS-CoV-…

… The inhibition of the SARS-CoV-2 main protease is necessary … to identify the possible
inhibitors of the SARS-CoV-2 main … bind to the active site of the SARS-CoV-2 protease (PDB: …

… molecule therapeutics for SARS-CoV-2. Along these efforts, the structure of SARS-CoV-2
main … ZINC15 library to identify top 1,000 potential ligands for SARS-CoV-2 Mpro protein. The …

… -7-glucoside-4′-neohesperidoside as potential inhibitors of Mpro and PLpro, respectively.
Other studies have also reported rutin as SARS-CoV-2 Mpro inhibitor (Huynh et al., 2020, …

… Its genome is about 82% identical to the SARS coronavirus (SARS-CoV). Specifically…
Potentially, it can block the binding of RBD to ACE2 and hence it can be used as a potential inhibitor…